- JP-listed companies
- Renascience Inc.
- Balance sheet
Renascience Inc. (4889) Balance sheet
Market cap
¥18.4B
P/E ratio
-53.3x
Rena Science develops pharmaceuticals, medical devices, and AI-powered software to address critical health challenges including cancer, diabetes, and age-related diseases.
| 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Cash and cash equivalents | - | 981 | 1,026 | 2,387 | 2,212 | 2,027 | 1,800 |
| Total cash & short-term investments | - | 981 | 1,026 | 2,387 | 2,212 | 2,027 | 1,800 |
| Total current assets | - | 988 | 1,043 | 2,428 | 2,267 | 2,086 | 1,871 |
| Property, plant and equipment, net | - | 3 | 4 | 4 | 4 | - | - |
| Total non-current assets | - | 25 | 24 | 10 | 7 | 2 | 0 |
| Total assets | - | 1,013 | 1,067 | 2,438 | 2,275 | 2,089 | 1,871 |
| Total current liabilities | - | 11 | 29 | 38 | 100 | 126 | 151 |
| Total non-current liabilities | - | 380 | 476 | 199 | 310 | 356 | - |
| Total liabilities | - | 391 | 505 | 237 | 410 | 482 | 151 |
| Retained earnings | - | -365 | -100 | -354 | -690 | -948 | -835 |
| Stockholders' equity | 806 | 622 | 562 | 2,201 | 1,865 | 1,607 | 1,720 |